About

The One Health Antimicrobial Resistance Research Programme (OHARP) is jointly funded by the Ministry of Health (MOH); National Environment Agency (NEA); National Parks Board/Animal & Veterinary Service (NParks/AVS); PUB, Singapore’s National Water Agency (PUB); and Singapore Food Agency (SFA). It is administered by the National Centre for Infectious Diseases to support One Health antimicrobial resistance (AMR) research across the human, animal, food and environmental sectors in Singapore.

The objective of the OHARP is to steer the national One Health AMR research agenda; commission multi-disciplinary and multi-sectorial studies that will impact Singapore’s AMR policies and interventions; foster partnerships with academia and harness their expertise to find One Health solutions; and promote synergies and opportunities for collaboration between sectors.

Research Areas of Focus

The second grant call will include:

• Open call for research in the transmission pathways of key AMR organisms across human, animal, food, water and/or other environments in Singapore
  AND
• Commissioned study on the socioeconomic impact of AMR which includes:
  • Scoping review to determine an approach or approaches for estimating the socioeconomic impact of AMR in Singapore using a One Health framework
  • Identify the data sources required, including data gaps in Singapore and where these can be filled by international published data
  • Estimate the socioeconomic impact of AMR in Singapore at the national and individual levels, and include projections for the future if nothing is done
  • Recommendations for estimating how interventions in different sectors might change or affect the projected socioeconomic cost of AMR

Eligibility

• Only one Corresponding Principal Investigator (PI) is allowed per application and is required to fulfil the following criteria at the point of application:
  
  • Holds an appointment in a local publicly funded institution and salaried by the institution
  • Be an independent PI with a demonstrated track record of research as evidenced by the award of nationally competitive funding (international funding to be considered on a case by case basis) or substantial publication record
  • Hold a minimum of 9-months employment with a local Singapore institution. Upon award, the PI must agree to fulfil at least 6 months of residency in Singapore for each calendar year over the duration of the grant award
  • Has no outstanding report from previous BMRC, NMRC grants, and other national grants
  • For proposals involving patient care, the PI should be SMC registered; or should be able to demonstrate ability to access patients through SMC registered Co-Is or collaborators

• Research should be conducted in more than one sector – human, animal, food and environment – and in Singapore. 
• The submitted proposal should meet the research grant’s objectives

Review Procedure

The application will be reviewed by the OHARP Scientific Panel and applicants will be notified of the outcome by end May 2022.  Applicants may be invited for an interview by the panel.

Funding Quantum and Duration

For the open call for transmission pathways of AMR, funding of up to $302,500 per project and research period from May 2022 to May 2025 (3 years).

For the commissioned study on socioeconomic impact of AMR, funding of up to $750,000 and research period from May 2022 to May 2025 (3 years).

Please refer to the respective application package for more details on the funding quantum and allocation across years.

Submission Instructions and Additional Information

Please click here for submission instructions and additional information on OHARP.

Roadshow

Interested applicants are invited to join the OHARP 2022 Grant Call Roadshow, held on 21 February 2021 (Monday), 12 – 1 PM on Zoom.

To register for the Roadshow, please click here. Successful registrants will be sent a confirmation email.

Contact

For enquiries on OHARP, please email oh_amr_research@ncid.sg.